Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.
D360 Express with ActivityBase connector is ideal for ActivityBase users who want quick and easy, single-point access to retrieve, analyze and share scientific data. It’s the only turnkey solution that seamlessly integrates ActivityBase with D360 Express to provide leading edge capabilities while minimizing IT cost and maintenance.
Read MoreD360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.
Read MoreD360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.
Read MoreD360 brings together data from different sources and provides integrated analysis and collaboration tools to support a wide variety of workflows across scientific disciplines.
Read MoreDiscovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.
Read MorePRINCETON, NJ – June 23, 2016 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.
Read MoreProviding scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.
Read MoreCertara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it. A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data. Toxicologists, pathologists, […]
Read MoreD360 enables scientists to easily access, analyze, and visualize chemical and biological data, enhance scientific capabilities. A small biotechnology company dedicated to the research and development of small molecule therapeutics engaged in an initiative to better address access and analysis of chemical and biological data by its scientists. Scientists at this company use IDBS’ ActivityBase®, […]
Read MoreA top 40 pharmaceutical company enhanced data access and decision support for pre-clinical safety with Certara’s D360 data access and analysis application and a specialized CDISC SEND-based database. Pre-clinical scientists at a top 40 pharmaceutical company faced delays of a day or more for data collation and transformation with each incremental data update received from […]
Read MoreDiscovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 Drug Discovery Platform A multi-national pharmaceutical company had developed a custom informatics system, providing all scientists in its discovery organization with access to essential research data. While information access was well-served by the tool, over time, a long list of new […]
Read MoreMedivir sees a fast return on its investment — time savings and enhanced informativeness of data activities The discovery arm of Medivir®, a mid-size, Swedish pharmaceutical company, sought an updated informatics infrastructure to improve the efficiency and flexibility of its data analysis and reporting. The group’s existing in-house tools could only create reports in a […]
Read MoreIn this paper, we explore the issues in the effective use of modern pharmaceutical data mining applications. We discuss the development and capabilities that were built into the Discovery 360° application to address these issues, as part of Wyeth Pharmaceuticals Next Generation IT project (NextGen). Wyeth found that simplifying data access and integration of data […]
Read More
As the end of the year draws near, I want to thank all of our customers for letting us be your biosimulation and model based drug development solution provider. We feel honored to be able to play a small, but crucial role in your success in bringing safe and effective drugs to patients. 2014 has […]
Read More
A recent report by Deloitte identified the #1 trend in the life sciences market as an increased focus on patient safety and enforcement. While it seems obvious to consider safety issues in approved drugs, regulatory agencies such as the FDA and EMA (European Medicines Agency) are extending their scrutiny to the entire drug development process, […]
Read MoreIn this webinar, David Lowis, D. Phil. of Certara, makes the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Joining Dr. Lowis will be Stuart Horowitz, PhD, President of Institutional Services at WIRB-Copernicus Group. Dr. Horowitz […]
Read More